van Raalte Daniel H, Goorden Susan M, Kemper Evelien A, Brosens Lodewijk A A, ten Kate Reinier W
Department of Internal Medicine, Kennemer Gasthuis, Haarlem, The Netherlands.
Atal Medial Diagnostic Centers, Hoofddorp, The Netherlands.
BMJ Case Rep. 2015 Jul 9;2015:bcr2015210189. doi: 10.1136/bcr-2015-210189.
Hypercalcaemia is frequently observed in patients with sarcoidosis. This is classically attributed to ectopic production of 1,25 dihydroxy vitamin D by sarcoid granulomas. We present a case of sarcoidosis-related hypercalcaemia with normal vitamin D levels. In this patient, production of parathyroid hormone-related peptide (PTHrp) was the cause for sarcoidosis-induced hypercalcaemia. As such, plasma PTHrp levels were increased and bone marrow granulomas stained positively for PTHrp expression. Medium-dose prednisolone treatment improved symptoms of sarcoidosis and normalised serum calcium, and PTHrp concentrations. Thus, production of PTHrp may be the cause for hypercalcaemia in some patients with sarcoidosis.
结节病患者常出现高钙血症。传统上认为这是由于结节病肉芽肿异位产生1,25-二羟维生素D所致。我们报告一例维生素D水平正常的结节病相关高钙血症病例。在该患者中,甲状旁腺激素相关肽(PTHrp)的产生是结节病诱发高钙血症的原因。因此,血浆PTHrp水平升高,骨髓肉芽肿PTHrp表达呈阳性染色。中等剂量泼尼松龙治疗改善了结节病症状,使血清钙和PTHrp浓度恢复正常。因此,PTHrp的产生可能是一些结节病患者高钙血症的原因。